Wednesday, August 7, 2019

How to MEND memory

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Related image

MEND is UCLA's 25-step personalized program to reverse memory loss. Nine of 10 participants displayed significant memory improvements. Learn how. Includes a chart summing-up the 25 steps. 




MEND is a novel, personalized and comprehensive program to reverse memory loss. In a recent MEND study, nine of 10 participants displayed subjective or objective improvement in their memories, beginning within three to six months after the program's start. Of the six patients who had to discontinue working or were struggling with their jobs at the time they joined the study, all were able to return to work or continue working with improved performance.

Continued below video...

Improvements have been sustained, and as of this writing, the longest patient follow-up is two and one-half years from initial treatment. These first ten included patients with memory loss associated with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), or subjective cognitive impairment (SCI; when a patient reports cognitive problems). One patient, diagnosed with late stage Alzheimer's, did not improve.

MEND: 25-Step Memory Program

GoalApproachNotes
Optimize diet: minimize simple carbohydrates, minimize inflammation.Patients given choice of several low glycemic, low inflammatory, low grain diets.Minimize inflammation, minimize insulin resistance.
Enhance autophagy, ketogenesisFast 12 hr each night, including 3 hr prior to bedtime.Reduce insulin levels, reduce Aβ.
Reduce stressPersonalized—yoga or meditation or music, etc.Reduction of cortisol, CRF, stress axis.
Optimize sleep8 hr sleep per night; melatonin 0.5mg po qhs; Trp 500mg po 3x/wk if awakening. Exclude sleep apnea.
Exercise30-60' per day, 4-6 days/wk
Brain stimulationPosit or related
Homocysteine <7 font="">Me-B12, MTHF, P5P; TMG if necessary
Serum B12 >500Me-B12
CRP <1 .0="" a="">1.5Anti-inflammatory diet; curcumin; DHA/EPA; optimize hygieneCritical role of inflammation in AD
Fasting insulin <7 font="" hgba1c="">Diet as aboveType II diabetes-AD relationship
Hormone balanceOptimize fT3, fT4, E2, T, progesterone, pregnenolone, cortisol
GI healthRepair if needed; prebiotics and probioticsAvoid inflammation, autoimmunity
Reduction of AβCurcumin, Ashwagandha
Cognitive enhancementBacopa monniera, MgT
25OH-D3 = 50-100ng/mlVitamins D3, K2
Increase NGFH. erinaceus or ALCAR
Provide synaptic structural componentsCiticoline, DHA
Optimize antioxidantsMixed tocopherols and tocotrienols, Se, blueberries, NAC, ascorbate, α-lipoic acid
Optimize Zn:fCu ratioDepends on values obtained
Ensure nocturnal oxygenationExclude or treat sleep apnea
Optimize mitochondrial functionCoQ or ubiquinol, α-lipoic acid, PQQ, NAC, ALCAR, Se, Zn, resveratrol, ascorbate, thiamine
Increase focusPantothenic acidAcetylcholine synthesis requirement
Increase SirT1 functionResveratrol
Exclude heavy metal toxicityEvaluate Hg, Pb, Cd; chelate if indicatedCNS effects of heavy metals
MCT effectsCoconut oil or Axona
KEY:
Hg, mercury; Pb, lead; Cd, cadmium; MCT, medium chain triglycerides; PQQ, polyquinoline quinone; NAC, N-acetyl cysteine; CoQ, coenzyme Q; ALCAR, acetyl-L-carnitine; DHA, docosahexaenoic acid; MgT, magnesium threonate; fT3, free triiodothyronine; fT4, free thyroxine; E2, estradiol; T, testosterone; Me-B12, methylcobalamin; MTHF, methyltetrahydrofolate; P5P, pyridoxal-5-phosphate; TMG, trimethylglycine; Trp, tryptophan

Encouraging Findings

The study, which comes jointly from the UCLA Mary S. Easton Center for Alzheimer's Disease Research and the Buck Institute for Research on Aging, is the first to suggest that memory loss in patients may be reversed, and improvement sustained, using a complex therapeutic program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.
The findings, published in the current online edition of the journal Aging, "are very encouraging. However, at the current time the results are anecdotal, and therefore a more extensive, controlled clinical trial is warranted," said Dale Bredesen, the Augustus Rose Professor of Neurology and Director of the Easton Center at UCLA, a professor at the Buck Institute, and the author of the paper.
In the case of Alzheimer's disease, Bredesen notes, there is not one drug that has been developed that stops or even slows the disease's progression, and drugs have only had modest effects on symptoms. "In the past decade alone, hundreds of clinical trials have been conducted for Alzheimer's at an aggregate cost of over a billion dollars, without success," he said.

Combination Therapy

Other chronic illnesses such as cardiovascular disease, cancer, and HIV, have been improved through the use of combination therapies, he noted. Yet in the case of Alzheimer's and other memory disorders, comprehensive combination therapies have not been explored. Yet over the past few decades, genetic and biochemical research has revealed an extensive network of molecular interactions involved in AD pathogenesis. "That suggested that a broader-based therapeutics approach, rather than a single drug that aims at a single target, may be feasible and potentially more effective for the treatment of cognitive decline due to Alzheimer's," said Bredesen.
While extensive preclinical studies from numerous laboratories have identified single pathogenetic targets for potential intervention, in human studies, such single target therapeutic approaches have not borne out. But, said Bredesen, it's possible addressing multiple targets within the network underlying Alzheimer's may be successful even when each target is affected in a relatively modest way. "In other words," he said, "the effects of the various targets may be additive, or even synergistic."
Given this, Bredesen thought that rather than a single targeted agent, the solution might be a systems type approach, the kind that is in line with the approach taken with other chronic illnesses -- a multiple-component system.
"The existing Alzheimer's drugs affect a single target, but Alzheimer's disease is more complex. Imagine having a roof with 36 holes in it, and your drug patched one hole very well -- the drug may have worked, a single "hole" may have been fixed, but you still have 35 other leaks, and so the underlying process may not be affected much."
“The shift to applying a broad combination therapy to Alzheimer’s is a crucial turning point towards effectively treating Alzheimer’s disease,” says Dr. Marwan N. Sabbagh, Research Professor of Neurology at the University of Arizona College of Medicine in Phoenix

Personalized Approach

Bredesen's approach is personalized to the patient, based on extensive testing to determine what is affecting the plasticity signaling network of the brain. As one example, in the case of the patient with a demanding job who was forgetting her way home, her therapeutic program consisted of some, but not all of the components involved with Bredesen's therapeutic program, and included:
  • (1) eliminating all simple carbohydrates, leading to a weight loss of 20 pounds;
  • (2) eliminating gluten and processed food from her diet, with increased vegetables, fruits, and non-farmed fish;
  • (3) to reduce stress, she began yoga;
  • (4) as a second measure to reduce the stress of her job, she began to meditate for 20 minutes twice per day;
  • (5) she took melatonin each night;
  • (6) she increased her sleep from 4-5 hours per night to 7-8 hours per night;
  • (7) she took methylcobalamin each day;
  • (8) she took vitamin D3 each day;
  • (9) fish oil each day;
  • (10) CoQ10 each day;
  • (11) she optimized her oral hygiene using an electric flosser and electric toothbrush;
  • (12) following discussion with her primary care provider, she reinstated hormone replacement therapy that had been discontinued;
  • (13) she fasted for a minimum of 12 hours between dinner and breakfast, and for a minimum of three hours between dinner and bedtime;
  • (14) she exercised for a minimum of 30 minutes, 4-6 days per week.

Pluses & Minuses

The results for nine of the 10 patients reported in the paper suggest that memory loss may be reversed, and improvement sustained with this therapeutic program, said Bredesen. "This is the first successful demonstration," he noted, but he cautioned that the results are anecdotal, and therefore a more extensive, controlled clinical trial is needed. "The current, anecdotal results require a larger trial, not only to confirm or refute the results reported here, but also to address key questions raised, such as the degree of improvement that can be achieved routinely, how late in the course of cognitive decline reversal can be effected, whether such an approach may be effective in patients with familial Alzheimer's disease, and last, how long improvement can be sustained," he said.
The downside to this program is its complexity. It is not easy to follow, with the burden falling on the patients and caregivers, and none of the patients were able to stick to the entire protocol.
On the other hand, the fact that there was such great memory improvement in so many patients shows that this is not an all-or-nothing program. Even doing some of the program's steps was enough to improve memory.
Even better, said Bredesen, are the program's side effects: "It is noteworthy that the major side effect of this therapeutic system is improved health and an optimal body mass index, a stark contrast to the side effects of many drugs."

Big Trial, Rapid Results

Muses Labs will soon launch a two-year observational study to conduct a large-scale trial of the MEND program. The trial will include 200+ participants with Alzheimer's disease, at selected medical facilities across the country.
Says Muses Labs’ CEO Vik Chandra, “Muses Labs intends to utilize the Internet and recent technology innovations to make personalized combination therapy practical and accessible to every individual with Alzheimer’s disease around the world.”
As the therapy does not rely upon new drugs, but rather an innovative combination of existing pharma and broader-based therapeutics, wider availability is only a couple of years away.

Sunday, August 4, 2019

How to calm those with dementia

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Sunday, July 28, 2019

How to know which foods mix well with dementia medication

Caregivers, and healthcare professionals,here is some great information

Here is a great 
dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best 
caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow 
alzheimersideas on twitter


The Dementia Caregiver's Little Book of Hope [Kindle Edition

What's tasty and what's not for people with Alzheimer's? Find out from Teepa Snow. Learn what to expect when medication is mixed with food. Turn meals into a real time for connecting.






Tuesday, July 23, 2019

How to lower dementia risk with hearing loss treatment

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]
Related image
hear.com — simply good hearing

PREVENTION & THERAPY INFOMERCIAL:

Research shows that for every 10 decibels of hearing loss, the risk of developing dementia increases. Learn how the right hearing aids can lower your risk.


Hearing Loss & Dementia

Researchers from John Hopkins recently completed an 18-year study showing participants who experienced hearing loss had an increased risk of developing dementia. A person’s risk of developing dementia increased with the severity of hearing loss. In another study, Gallacher et al concluded that for every 10 decibels of hearing loss, the risk of developing dementia increased. 

How does hearing loss impair the brain? When the ears stop hearing certain sounds and frequencies, the brain turns off the areas needed to process those sounds. The brain also begins to shrink. MRIs show that adults with untreated hearing loss lose about a cubic centimeter of brain tissue per year.

Hearing Aids May Lower the Risk of Dementia

Hearing aids receive sounds from your environment and only amplify the sounds your ears had stopped perceiving. This technology enables the brain to recognize and process those frequencies again. Therefore, the brain continues working in those areas! By keeping your brain engaged, brain shrinkage occurs more slowly and the risk for developing dementia may be lowered. 

Hearing aids also help people maintain physical, emotional, and cognitive health by giving them the chance to participate in conversations and social activities. Surveys conducted in Europe revealed hearing aid users are less tired at the end of the day and have more restful sleeps. Hearing aids users are also less depressed. In conclusion, hearing aids provide many benefits, from keeping you happy to keeping your brain healthy. 

To learn more about hearing aids and how to start wearing them, request a free consultation from hear.com. Knowledgeable experts will connect you with the top hearing specialists in your area and provide you with the most effective hearing aids available. 

Start your consultation now » 


SOURCE:
  • hear.com — simply good hearing
    396 Alhambra Circle, Suite S-700
    Coral Gables, FL 33134

Monday, July 15, 2019

Best Alzheimer's Drugs

Image result for pills pictures

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

St. Michael's Hospital: 
See safety and effectiveness rankings for four Alzheimer's drugs. Ranked on concentration, memory, alertness and mood, learn what the researchers found. 




An important study, ranking the safety and effectiveness of four drugs taken to enhance concentration, memory, alertness and moods, found that donepezil was most likely to effectively improve cognition in patients with Alzheimer's dementia. 

However, patients who took donepezil were more likely to experience side effects including nausea, vomiting and diarrhea than those who received a placebo, according to the study, published online in the Journal of the American Geriatrics Society.

Improving Cognition in Alzheimer's

Drugs for Early to Midstage
Brand NameGeneric Name
Aricept®donepezil
Exelon®rivastigmine
Remynil or Razadyne®galantamine
Drugs for Moderate to Severe Stage
Namenda® or Ebixa®memantine
In 2015, 46 million people worldwide had Alzheimer's disease, according to the study. In 2013, 146,593 people aged 65 and older in Ontario alone used cognitive enhancers, according to a 2016 Ontario Drug Policy Research report. 

"Alzheimer's dementia is the most common form of dementia in North America, and most people who have moderate to severe Alzheimer's will be on these medications," said Dr. Andrea Tricco, a scientist in the Li Ka Shing Knowledge Institute of St. Michael's Hospital and lead author of the study. "This analysis will give both patients and clinicians a full picture of how each of these drugs will likely affect their cognition, as well as their overall health."

Safety & Effectiveness

Although there have been previous reviews of the safety and effectiveness of cognitive enhancers in treating Alzheimer's dementia, the authors said this was the first to rank their comparative safety and effectiveness. 

The study used network meta-analysis, an advanced statistical analysis technique, to systematically review existing evidence from 142 clinical trials of four common cognitive enhancers administered alone or in combination published between 1996 and 2015. The number of patients in each study ranged from 13 to 2,045, and the review evaluated a total of 33,889 patients. 




The researchers compared the safety and effectiveness of any combination of donepezil, rivastigmine, galantamine or memantine in treating moderate to severe Alzheimer's dementia based on the results of the clinical trials that examined a number of patient outcomes, including cognition, function behaviour, global status, mortality, serious adverse events, falls, bradycardia, headache, diarrhea, vomiting and nausea. Donepezil was likely the most effective medication for Alzheimer's dementia across all effectiveness outcomes, including cognition, behavior and overall health, according to the study.

Best Course of Alzheimer's Treatment

Donepezil was also the only cognitive enhancer that reached the minimal clinically important threshold -- meaning effects on outcomes were observed clinically, as well as statistically -- on the Alzheimer's Disease Assessment cognition scale, making it the likely first choice for those patients and clinicians considering these medications, the authors said.

Although no significant risk of serious harm, falls or reduced heart rate was associated with any of the medications in the study, the data was limited on these specific outcomes.

Previous research by the authors found that cognitive enhancers do not improve cognition or function in people with mild cognitive impairment, and these patients experience significantly more nausea, diarrhea, vomiting and headaches.

The findings of the current study will help guide patients and clinicians who are making decisions about the best course of treatment for Alzheimer's dementia, said Dr. Tricco.

"The more information we are able to gather about how each of these medications can affect a patient's cognition and health, the more likely we are to be able to improve their health outcomes," she said.

REFERENCE:
SOURCE:
  • St. Michael's Hospital:
    St. Michael’s Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 29 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the Hospital’s recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael’s Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the U
    niversity of Toronto.

Friday, July 12, 2019

How nuts help the brain

Image result for peanuts pictures

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

University of South Australia

In 4,000 elders, nuts boosted cognition by 60% and delayed memory decline by 2 years. See the "Healthy Nuts" chart, detailing the benefits of 10 different nuts. Watch these videos to learn why long-term, high nut consumption is a key to better thinking in older adults. 




Long-term, high nut consumption could be the key to better cognitive health in older people according to new research from the University of South Australia. 


In a study of 4822 Chinese adults aged 55+ years, researchers found that eating more than 10 grams of nuts a day was positively associated with better mental functioning, including improved thinking, reasoning and memory.

Cognition & Nut Intake

Lead researcher, UniSA's Dr Ming Li, says the study is the first to report an association between cognition and nut intake in older Chinese adults, providing important insights into increasing mental health issues (including dementia) faced by an ageing population. 

"Population aging is one of the most substantial challenges of the twenty-first century. Not only are people living longer, but as they age, they require additional health support which is placing unprecedented pressure on aged-care and health services," Dr Li says.

Nuts are a Preventative Dietary Modification

"In China, this is a massive issue, as the population is ageing far more rapidly than almost any other country in the world. 

"Improved and preventative health care -- including dietary modifications -- can help address the challenges that an aging population presents.

Two Teaspoons Vs. No Teaspoons of Nuts

"By eating more than 10 grams (or two teaspoons) of nuts per day older people could improve their cognitive function by up to 60 per cent- compared to those not eating nuts -- effectively warding off what would normally be experienced as a natural two-year cognition decline." 

China has one of the fastest growing aging populations. In 2029, China's population is projected to peak at 1.44 billion, with the ratio of young to old dramatically imbalanced by the rising ranks of the elderly. By 2050, 330 million Chinese will be over age 65, and 90.4 million will be over age 80, representing the world's largest population of this most elderly age group.

17% Consume Nuts Regularly

More broadly, the World Health Organization says that by 2020, the number of people aged 60 years and older will outnumber children younger than five years old. 

The UniSA study analysed nine waves of China Health Nutrition Survey data collected over 22 years, finding that 17 per cent of participants were regular consumers of nuts (mostly peanuts). Dr Li says peanuts have specific anti-inflammatory and antioxidant effects which can alleviate and reduce cognitive decline.

No Cure, But Nuts Offer Improvements

"Nuts are known to be high in healthy fats, protein and fibre with nutritional properties that can lower cholesterol and improve cognitive health," Dr Li says. 

"While there is no cure for age-related cognition decline and neurogenerative disease, variations in what people eat are delivering improvements for older people." 

The World Health Organization estimates that globally, the number of people living with dementia is at 47 million.

Modifying Diet Worth the Effort

By 2030, this is projected to rise to 75 million and by 2050, global dementia cases are estimated to almost triple. China has the largest population of people with dementia.x 

"As people age, they naturally experience changes to conceptual reasoning, memory, and processing speed. This is all part of the normal ageing process," Dr. Li says. 

"But age is also the strongest known risk factor for cognitive disease. If we can find ways to help older people retain their cognitive health and independence for longer -- even by modifying their diet -- then this absolutely worth the effort." 





Saturday, July 6, 2019

How do lettuce and oil protect the brain

250+ ORGANICALLY Grown Arugula Roquette Rocket Seeds Heirloom Non-GMO Delicious and Healthy, Eruca Sativa, from USA

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


King's College London


A diet that combines unsaturated fats with nitrite-rich vegetables, such as olive oil and lettuce, can protect you from hypertension and vascular dementia. Learn which foods are helpful and why.




A diet that combines unsaturated fats with nitrite-rich vegetables, such as olive oil and lettuce, can protect you from hypertension, suggests a dietary study led by King's College London. Hypertension is a major risk factor for vascular dementia.

The findings, published in the journal PNAS, help to explain why some previous studies have shown that a Mediterranean diet can reduce blood pressure.

The Mediterranean diet typically includes unsaturated fats found in:

  • olive oil,
  • nuts
  • avocados,
along with vegetables that are rich in nitrites and nitrates like: 
  • spinach,
  • celery
  • carrots.
When these two food groups are combined, the reaction of unsaturated fatty acids with nitrogen compounds in the vegetables results in the formation of nitro fatty acids.

The study, supported by the British Heart Foundation, used mice to investigate the process by which these nitro fatty acids lower blood pressure, looking at whether they inhibited an enzyme known as soluble Epoxide Hydrolase which regulates blood pressure.

Mice genetically engineered to be resistant to this inhibitory process were found to maintain their high blood pressure despite being fed the type of nitro fatty acids that normally form when a Mediterranean diet is consumed. However, nitro fatty acids were found to lower the blood pressure of normal mice following the same diets.

Thus, the study concludes that the protective effect of the Mediterranean diet, combining unsaturated fats and vegetables abundant in nitrite and nitrate, comes at least in part from the nitro fatty acids generated which inhibit soluble Epoxide Hydrolase to lower blood pressure.

Professor Philip Eaton, Professor of Cardiovascular Biochemistry at King's College London, said: 

"The findings of our study help to explain why previous research has shown that a Mediterranean diet supplemented with extra-virgin olive oil or nuts can reduce the incidence of cardiovascular problems like stroke, heart failure and heart attacks."


Source:

Journal Reference:
  1. Rebecca L. Charles, Olena Rudyk, Oleksandra Prysyazhna, Alisa Kamynina, Jun Yang, Christophe Morisseau, Bruce D. Hammock, Bruce A. Freeman, and Philip Eaton. Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase. PNAS, May 2014 DOI: 10.1073/pnas.1402965111
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info